Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Change in Cash (2016 - 2025)

CNBX Pharmaceuticals (CNBX) has disclosed Change in Cash for 13 consecutive years, with -$7408.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 18.39% year-over-year to -$7408.0, compared with a TTM value of -$9636.0 through Nov 2025, up 85.02%, and an annual FY2025 reading of -$11305.0, up 89.05% over the prior year.
  • Change in Cash was -$7408.0 for Q4 2025 at CNBX Pharmaceuticals, down from $1463.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $1.2 million in Q1 2021 and bottomed at -$600058.0 in Q4 2021.
  • Average Change in Cash over 5 years is -$8573.8, with a median of -$8242.5 recorded in 2024.
  • Peak annual rise in Change in Cash hit 1108.17% in 2024, while the deepest fall reached 270.2% in 2024.
  • Year by year, Change in Cash stood at -$600058.0 in 2021, then surged by 84.02% to -$95915.0 in 2022, then surged by 49.9% to -$48049.0 in 2023, then skyrocketed by 81.11% to -$9077.0 in 2024, then increased by 18.39% to -$7408.0 in 2025.
  • Business Quant data shows Change in Cash for CNBX at -$7408.0 in Q4 2025, $1463.0 in Q3 2025, and -$32027.0 in Q2 2025.